Correlation Between BC Bud and Aequus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BC Bud and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BC Bud and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The BC Bud and Aequus Pharmaceuticals, you can compare the effects of market volatilities on BC Bud and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BC Bud with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BC Bud and Aequus Pharmaceuticals.
Diversification Opportunities for BC Bud and Aequus Pharmaceuticals
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BCBCF and Aequus is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding The BC Bud and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and BC Bud is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The BC Bud are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of BC Bud i.e., BC Bud and Aequus Pharmaceuticals go up and down completely randomly.
Pair Corralation between BC Bud and Aequus Pharmaceuticals
Assuming the 90 days horizon The BC Bud is expected to generate 4.49 times more return on investment than Aequus Pharmaceuticals. However, BC Bud is 4.49 times more volatile than Aequus Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 0.30 in The BC Bud on October 20, 2024 and sell it today you would earn a total of 8.47 from holding The BC Bud or generate 2823.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
The BC Bud vs. Aequus Pharmaceuticals
Performance |
Timeline |
BC Bud |
Aequus Pharmaceuticals |
BC Bud and Aequus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BC Bud and Aequus Pharmaceuticals
The main advantage of trading using opposite BC Bud and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BC Bud position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.BC Bud vs. Amexdrug | BC Bud vs. Crescita Therapeutics | BC Bud vs. Aion Therapeutic | BC Bud vs. Alterola Biotech |
Aequus Pharmaceuticals vs. Solitron Devices | Aequus Pharmaceuticals vs. Ieh Corp | Aequus Pharmaceuticals vs. SCI Engineered Materials | Aequus Pharmaceuticals vs. Surge Components |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |